MedPage Today on MSN
Dual GIP/GLP-1 drug linked to reduced diabetic retinopathy incidence
However, concerns about the impact of rapid glycemic control on diabetic retinopathy risk ...
Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...
The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...
STOCKHOLM — At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting, researchers discussed how insights into potential risk factors and new treatments could improve outcomes for ...
Retinopathy refers to conditions or damage affecting the retina. Without treatment, it can cause blindness. Hypertensive retinopathy results from high blood pressure, while diabetic retinopathy is a ...
CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that clinical data from the company’s ...
Proliferative diabetic retinopathy and non-proliferative diabetic retinopathy are stages of diabetic retinopathy. The former is the more severe form that can lead to vision loss. Unmanaged diabetes ...
Fundus photography involves taking a photo of the back of the eye to detect signs of diabetic retinopathy. It is also possible to capture an image of the retina using a smartphone. Diabetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results